GS LHF 75 mg (Tafinlar 75 mg)
Generic Name: dabrafenib
Pill imprint GS LHF 75 mg has been identified as Tafinlar 75 mg.
Tafinlar is used in the treatment of melanoma, metastatic and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tafinlar 75 mg Unknown
See also related documents.
Images for GS LHF 75 mg (Tafinlar 75 mg)
Tafinlar is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...